StudyU: a platform for designing and conducting innovative digital N-of-1 trials
Preprint
Abstract
N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully-functional platforms are not yet available. Here, we present the open source StudyU platform which includes the StudyU designer and StudyU app. With the StudyU designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone application with innovative user-centric elements for participants to partake in the published trials and assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- The microrandomized trial for developing digital interventions: Experimental design and data analysis considerations.Psychological Methods, 2022
- Acute and Chronic Stress in Daily Police Service: A Three-Week N-of-1 StudyPsychoneuroendocrinology, 2020
- Time to reality check the promises of machine learning-powered precision medicineThe Lancet Digital Health, 2020
- From Real‐World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying ChallengesClinical Pharmacology & Therapeutics, 2020
- Real-time monitoring technology in single-case experimental design research: Opportunities and challengesBehaviour Research and Therapy, 2019
- Assessing Time-Varying Causal Effect Moderation in Mobile HealthJournal of the American Statistical Association, 2018
- Individual patients are the primary source and the target of clinical researchJournal of Clinical Epidemiology, 2016
- To meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHDJournal of Clinical Epidemiology, 2016
- The mPower study, Parkinson disease mobile data collected using ResearchKitScientific Data, 2016
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug responseNature Reviews Drug Discovery, 2011